Zihang Xu

1.5k total citations
67 papers, 834 citations indexed

About

Zihang Xu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zihang Xu has authored 67 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Cancer Research. Recurrent topics in Zihang Xu's work include Immune cells in cancer (8 papers), Immune Cell Function and Interaction (4 papers) and Cancer Mechanisms and Therapy (4 papers). Zihang Xu is often cited by papers focused on Immune cells in cancer (8 papers), Immune Cell Function and Interaction (4 papers) and Cancer Mechanisms and Therapy (4 papers). Zihang Xu collaborates with scholars based in China, United States and Russia. Zihang Xu's co-authors include Chunpu Zou, Fei Zhang, Xiaowen Zhu, Chenyuan Gong, Xiaohong Chen, Chao Yao, Chao Yao, Ye Yuan, Suyun Li and Shiguo Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Hazardous Materials.

In The Last Decade

Zihang Xu

53 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zihang Xu China 15 454 181 144 113 78 67 834
Zhiquan Chen China 20 495 1.1× 130 0.7× 143 1.0× 102 0.9× 62 0.8× 37 910
Chenxi Li China 19 607 1.3× 219 1.2× 146 1.0× 82 0.7× 53 0.7× 62 1.1k
Mahsa Zarei United States 16 402 0.9× 170 0.9× 203 1.4× 94 0.8× 67 0.9× 32 813
Mengyao Sun China 15 414 0.9× 125 0.7× 97 0.7× 76 0.7× 60 0.8× 36 725
J. Yuan China 18 481 1.1× 148 0.8× 217 1.5× 98 0.9× 42 0.5× 36 834
Danrong Li China 18 426 0.9× 191 1.1× 240 1.7× 128 1.1× 56 0.7× 64 1.0k
Xiaoyi Zhang China 14 611 1.3× 144 0.8× 148 1.0× 65 0.6× 75 1.0× 29 967
Youwen Chen China 15 546 1.2× 171 0.9× 222 1.5× 74 0.7× 84 1.1× 51 1.3k
Zhen Sun China 17 495 1.1× 281 1.6× 143 1.0× 111 1.0× 39 0.5× 38 899

Countries citing papers authored by Zihang Xu

Since Specialization
Citations

This map shows the geographic impact of Zihang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihang Xu more than expected).

Fields of papers citing papers by Zihang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihang Xu. The network helps show where Zihang Xu may publish in the future.

Co-authorship network of co-authors of Zihang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zihang Xu. A scholar is included among the top collaborators of Zihang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihang Xu. Zihang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Chaojun, Tao Cui, Zihang Xu, et al.. (2025). Inhibiting HMGB1/AGER/NF-κB pathway prevents pro-inflammatory microglia polarization and protect photoreceptors in retinitis pigmentosa. International Immunopharmacology. 149. 114192–114192. 3 indexed citations
2.
Yang, Xiaoyu, Zihang Xu, Hong Zhang, et al.. (2025). A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers. Arthritis Research & Therapy. 27(1). 75–75. 2 indexed citations
3.
4.
Zhang, Shouyu, et al.. (2025). Effect of hydrothermal and hydrothermal oxidation pretreatment on the physicochemical properties of biochar pellet and activated carbon prepared from biomass wastes. Journal of Analytical and Applied Pyrolysis. 188. 107007–107007. 4 indexed citations
5.
6.
Li, Heming, Lu Xu, Tao Han, et al.. (2024). Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 129–129. 11 indexed citations
7.
Zhang, Xinrong, Shengding Hu, Zihang Xu, et al.. (2024). Beyond the Turn-Based Game: Enabling Real-Time Conversations with Duplex Models. 11543–11557.
8.
9.
Chen, Xi, Xi Chen, Lin Su, et al.. (2024). Ze-Qi-Tang formula inhibits MDSCs glycolysis through the down-regulation of p21/Hif1α/Glut1 signal in psoriatic-like mice. Phytomedicine. 130. 155544–155544. 5 indexed citations
10.
Zhang, Huimin, Lin Su, Mingxi Liu, et al.. (2023). Targeting upregulation of the immunosuppressive activity of MDSCs with indirubin as a novel strategy to alleviate psoriasis. International Immunopharmacology. 123. 110710–110710. 2 indexed citations
11.
Sun, Xuemei, et al.. (2023). Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer. Frontiers in Oncology. 13. 1086480–1086480. 12 indexed citations
12.
13.
Xu, Midie, Xing Zhang, Kexin Su, et al.. (2023). Gambogenic acid inhibits proliferation and ferroptosis by targeting the miR‐1291/FOXA2 and AMPKα/SLC7A11/GPX4 axis in colorectal cancer. Cell Biology International. 47(11). 1813–1824. 17 indexed citations
14.
Xu, Zihang, et al.. (2023). In situreconstructed AgZn3nanoparticles supported on zinc nanoplates for efficient CO2electroreduction to tunable syngas. Chemical Communications. 59(55). 8596–8599. 12 indexed citations
15.
16.
He, Mingyu, Gege Yan, Yang Wang, et al.. (2021). Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR. Journal of Cellular and Molecular Medicine. 25(11). 4962–4973. 11 indexed citations
17.
18.
Kim, Byunghyun, et al.. (2019). Erjingwan Extracts Exert Antiaging Effects of Skin through Activating Nrf2 and Inhibiting NF-κB. Evidence-based Complementary and Alternative Medicine. 2019. 1–15. 7 indexed citations
19.
Wang, Xiaotong, Zhenbo Han, Ying Yu, et al.. (2018). Potential Applications of Induced Pluripotent Stem Cells for Cardiovascular Diseases. Current Drug Targets. 20(7). 763–774. 6 indexed citations
20.
Xu, Zihang, et al.. (2017). Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. Journal of Experimental & Clinical Cancer Research. 36(1). 124–124. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiquan Chen Breakdown of academic impact, for papers by Chenxi Li Breakdown of academic impact, for papers by Mahsa Zarei Breakdown of academic impact, for papers by Mengyao Sun Breakdown of academic impact, for papers by J. Yuan Breakdown of academic impact, for papers by Danrong Li Breakdown of academic impact, for papers by Xiaoyi Zhang Breakdown of academic impact, for papers by Youwen Chen Breakdown of academic impact, for papers by Zhen Sun
Rankless by CCL
2026